Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IDEAYA Biosciences, Inc. - Common Stock (NQ:IDYA)

37.86 +1.55 (+4.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IDEAYA Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
AppLovin, Unity Software And Some Other Big Losers From Monday ↗
U.S. stocks closed higher on Monday, with the Dow Jones gaining around 150 points. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
News headline image
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday ↗
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month. 
Via Benzinga
News headline image
Why IDEAYA Biosciences Shares Plunging Today ↗
 
Via Benzinga
News headline image
Gold Drops Over 1%; Viridian Therapeutics Shares Spike Higher ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones around 170 points on Monday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
  
Via Benzinga
News headline image
Stocks Trim Morning Losses Ahead Of Retail Earnings ↗
Investors are eyeing an influx of earnings from the retail sector later in the week. 
Via Talk Markets
News headline image
Dow Surges Over 100 Points; Crude Oil Falls Sharply ↗
U.S. stocks traded turned higher midway through trading, with the Dow Jones gaining more than 100 points on Monday. 
Via Benzinga
News headline image
U.S. Stocks Edge Lower; NY Empire State Manufacturing Index Drops In August ↗
U.S. stocks traded slightly lower this morning, with the Dow Jones dropping around 40 points on Monday. 
Via Benzinga
News headline image
Recap: IDEAYA Biosciences Q1 Earnings ↗
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
IDEAYA Advances IDE161 Into IND-Enabling Studies, Exercises Licensing Option For PARG Inhibitors ↗
IDEAYA Biosciences Inc (NASDAQ: IDYA) has  
Via Benzinga
News headline image
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New... 
Via Benzinga
News headline image
Recap: IDEAYA Biosciences Q2 Earnings ↗
  IDEAYA Biosciences (NASDAQ:IDYA) reported its Q2 earnings results on Monday, August 15, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings IDEAYA Biosciences missed... 
Via Benzinga
News headline image
Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗
 
Via Benzinga
News headline image
IDEAYA's Cancer Candidate Shows Early Tumor Modulation ↗
 
Via Benzinga
News headline image
Ideaya Nominates Potential First-In-Class Pol Theta Helicase Inhibitor In Collaboration With GSK ↗
 
Via Benzinga
News headline image
FDA Grants Orphan Drug Designation For IDEAYA's Darovasertib For Uveal Melanoma ↗
The U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to IDEAYA Biosciences (NASDAQ: IDYA) for its drug candidate Darovasertib for the treatment of uveal melanoma. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Incannex Healthcare (NASDAQ:IXHL) stock moved upwards by 92.3% to $44.04 during Tuesday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
On Wednesday, 90 companies set new 52-week lows. Areas of Significance In Today's 52-Week Lows: The company with the largest market cap to set a new 52-week low was... 
Via Benzinga
News headline image
Ideaya Biosciences' IDE397 Shows Preliminary Tolerability In Early-Stage Solid Tumor Trial ↗
IDEAYA Biosciences Inc (NASDAQ: IDYA) has announced  
Via Benzinga
News headline image
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Recap: IDEAYA Biosciences Q4 Earnings ↗
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q4 earnings results on Tuesday, March 15, 2022 at 06:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
News headline image
IDEAYA Biosciences's Earnings: A Preview ↗
IDEAYA Biosciences (NASDAQ:IDYA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
IDEAYA Biosciences Inc. (NASDAQ: IDYA) Featured in Virtual Coverage of the 34th Annual Roth Conference
Via Investor Brand Network
News headline image
Earnings Scheduled For March 15, 2022 ↗
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2022 ↗
Upgrades For Alpha Metallurgical Resources Inc (NYSE:AMR), B. Riley Securities upgraded the previous rating of Neutral to Buy. For the fourth quarter, Alpha Metallurgical... 
Via Benzinga
News headline image
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments... 
Via Benzinga
News headline image
Ideaya Reports New Data From Combo Therapy Regime In Pretreated Eye Cancer Patients ↗
Ideaya Biosciences Inc (NASDAQ: IDYA) provided a clinical data update for the Phase 1/2 trial evaluating darovasertib and crizotinib synthetic lethal combination in... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
On Wednesday, 115 companies reached new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.